Fig. 3From: Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients?Therapeutic suggestions in COPD, taking also into account results of recent FLAME trial and the post-hoc analysis of the WISDOM trial. Elaboration of textual data from [51, 52]Back to article page